Zydus Wellness Limited (ZYDUSWELL) AI Stock Analysis

• Market Cap: ₹135.65B
• Dividend Yield: 0.28%
• Average Volume (3M): 15.16K
• Price to Earnings (P/E): 53.5
• Beta (1Y): 0.93
• Revenue Growth: 14.55%
• EPS Growth: -20.61%
• Country: IN
• Employees: 1,008
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): -0.60
• Shares Outstanding: 318,160,700
• 10 Day Avg. Volume: 9,092
• 30 Day Avg. Volume: 15,161
• PEG Ratio: 0.21
• Price to Book (P/B): 0.38
• Price to Sales (P/S): 0.79
• P/FCF Ratio: 6.81
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ₹460.00 ▲(8.26% Upside)

Zydus Wellness Limited's overall stock score is primarily driven by its strong financial performance, characterized by consistent revenue growth and a robust balance sheet. However, the technical analysis indicates bearish momentum, and the high P/E ratio suggests potential overvaluation, which tempers the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.

Balance Sheet Health

A strong balance sheet with low leverage enhances financial stability and provides flexibility for strategic investments and growth opportunities.

ESG Rating

A strong ESG rating reflects the company's commitment to sustainable practices, potentially enhancing its reputation and attractiveness to investors.

Negative Factors

Earnings Decline

A decline in earnings per share indicates potential challenges in profitability, which could impact future financial performance and investor confidence.

Profit Margin Pressure

Pressure on profit margins suggests rising costs or pricing challenges, which could affect profitability and require strategic cost management.

Cash Flow Variability

Variability in cash flow management may limit the company's ability to fund operations and growth initiatives, impacting financial flexibility.

Zydus Wellness Limited Business Overview & Revenue Model

Company Description

Zydus Wellness Limited (ZYDUSWELL) is a prominent player in the Indian wellness and healthcare sector, focusing on providing health-oriented products and solutions. As a subsidiary of Zydus Cadila, the company operates primarily in the consumer wellness segment, offering a diverse range of products including dietary supplements, health foods, and personal care items. Its portfolio features well-known brands such as Nutralite, Sugar Free, and EverYuth, catering to the growing consumer demand for healthier lifestyle choices.

How the Company Makes Money

Zydus Wellness Limited generates revenue through several key streams, primarily from the sale of its various health and wellness products. The company leverages its established brand reputation to capture market share in the growing health-conscious consumer segment. Revenue is significantly derived from retail sales across various channels, including supermarkets, pharmacies, and online platforms. Additionally, Zydus Wellness engages in strategic partnerships with retailers and distribution networks to enhance product visibility and accessibility. The company also invests in marketing and promotional activities to drive brand awareness and consumer engagement, further contributing to its sales growth. Overall, the combination of strong brand equity, diverse product offerings, and strategic market positioning underpins Zydus Wellness's revenue generation strategy.

Zydus Wellness Limited Financial Statement Overview

Summary

Zydus Wellness Limited exhibits strong financial performance with consistent revenue growth and solid margins. The company maintains a low debt-to-equity ratio and demonstrates efficient cash flow management, positioning it well for future growth. However, there is a slight concern regarding the decline in gross profit margin.

Income Statement

Zydus Wellness Limited has demonstrated strong income statement metrics with consistent revenue growth, achieving a 15.59% increase year-over-year for 2025. The company maintains solid margins with a gross profit margin of 43.29% and a net profit margin of 12.89%. The EBIT and EBITDA margins are also robust at 13.05% and 14.83% respectively. These figures indicate effective cost management and profitability. However, the gross profit saw a slight decline from the previous year, which could indicate rising costs or pricing pressures.

Balance Sheet

The balance sheet of Zydus Wellness Limited is strong, with a low debt-to-equity ratio of 0.03 indicating minimal leverage and financial risk. The company has a high equity ratio of 88.03%, reflecting a stable financial foundation. Return on equity (ROE) is impressive at 6.11%, showcasing efficient use of shareholder capital to generate profits. The overall stability and low leverage position the company well for future growth.

Cash Flow

Zydus Wellness has demonstrated strong cash flow management, with a free cash flow growth rate of 43.99% in 2025. The operating cash flow to net income ratio is 1.10, indicating that operating cash flow comfortably covers net income, highlighting operational efficiency. The free cash flow to net income ratio of 0.90 further emphasizes the company's ability to generate cash after capital expenditures. This solid cash flow performance supports its financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	27.13B	27.09B	23.28B	22.55B	20.09B	18.67B
Gross Profit	13.32B	10.77B	8.87B	10.96B	7.41B	10.08B
EBITDA	3.98B	3.99B	3.08B	3.32B	3.55B	2.21B
Net Income	3.27B	3.47B	2.67B	3.10B	3.09B	1.19B
Balance Sheet
Total Assets	0.00	64.42B	61.48B	58.33B	56.92B	56.66B
Cash, Cash Equivalents and Short-Term Investments	1.09B	1.29B	3.16B	1.08B	1.96B	2.52B
Total Debt	0.00	1.88B	3.29B	2.97B	3.87B	5.50B
Total Liabilities	-56.72B	7.70B	7.91B	7.11B	8.48B	10.99B
Stockholders Equity	56.72B	56.72B	53.58B	51.23B	48.44B	45.68B
Cash Flow
Free Cash Flow	0.00	3.14B	2.18B	467.00M	1.61B	2.67B
Operating Cash Flow	0.00	3.80B	2.46B	917.00M	2.37B	2.87B
Investing Cash Flow	0.00	-2.24B	-1.78B	-849.00M	-859.50M	-104.10M
Financing Cash Flow	0.00	-1.86B	-257.00M	-1.39B	-2.34B	-2.16B

Zydus Wellness Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 424.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ZYDUSWELL, the sentiment is Negative. The current price of 424.9 is below the 20-day moving average (MA) of 427.46, below the 50-day MA of 450.83, and above the 200-day MA of 407.14, indicating a neutral trend. The MACD of -7.67 indicates Negative momentum. The RSI at 41.02 is Neutral, neither overbought nor oversold. The STOCH value of 75.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ZYDUSWELL.

Zydus Wellness Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FINEORG	68 Neutral	₹131.57B	32.45	―	0.25%	5.73%	-7.74%
BECTORFOOD	66 Neutral	₹76.81B	56.34	―	0.45%	10.82%	-8.21%
ZYDUSWELL	66 Neutral	₹135.65B	53.53	―	0.28%	14.55%	-20.61%
PGIL	66 Neutral	₹74.88B	28.13	―	0.77%	24.93%	20.57%
BIKAJI	64 Neutral	₹185.95B	87.37	―	0.13%	11.04%	-26.83%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
JYOTHYLAB	61 Neutral	₹105.67B	30.34	―	1.23%	1.62%	-7.32%

Zydus Wellness Limited Corporate Events

Zydus Wellness CEO Acquires Additional Shares

Zydus Wellness Limited has announced a disclosure under the SEBI (Prohibition of Insider Trading) Regulations, 2015, pertaining to the acquisition of equity shares by its CEO and Whole Time Director, Mr. Tarun Arora. Mr. Arora acquired 1,000 equity shares from the open market, increasing his total shareholding to 11,000 shares. This move is part of the continual disclosure requirements under the SEBI regulations, ensuring transparency and compliance with insider trading laws.

Zydus Wellness Releases Q2 FY2026 Earnings Call Transcript

Zydus Wellness Limited announced the release of the transcript from its Q2 FY2026 earnings conference call, which was held on November 5, 2025. This disclosure, in compliance with SEBI regulations, provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting investor confidence and market positioning.

Zydus Wellness Achieves ‘Very Good’ ESG Rating

Zydus Wellness Limited has received an ESG rating of ’73’ with a grade of B+ and category ‘Very Good’ from CFC Finlease Private Limited, based on publicly available information. This rating reflects positively on the company’s commitment to environmental, social, and governance standards, potentially enhancing its reputation and appeal among stakeholders and investors.